• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-4和干扰素-γ对CD34+造血祖细胞上CD38和人类白细胞抗原-DR表达的差异调节

Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.

作者信息

Snoeck H W, Lardon F, Lenjou M, Nys G, Van Bockstaele D R, Peetermans M E

机构信息

Laboratory of Experimental Hematology, University of Antwerp (UIA), Belgium.

出版信息

Exp Hematol. 1993 Oct;21(11):1480-6.

PMID:7691636
Abstract

We studied the effects of interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) on the expression of CD38 and human leukocyte antigen (HLA)-DR on purified CD34+ bone marrow progenitor cells. CD34+CD38- and CD34+HLA-DR- cells are largely nonoverlapping populations. After culture for 4 days in IFN-gamma, the expression of CD38 and HLA-DR is significantly increased and the disappearance of the CD38- and HLA-DR- populations is virtually complete. Moreover, IFN-gamma induces a population of CD34+ cells with a very high expression of CD38 (CD34+CD38++ cells), which were absent in the initial CD34+ population. IL-4 has no effect on the expression of CD38, but induces a limited but significant increase in the expression of HLA-Dr. After culture in IFN-gamma, CD34+ cells show a higher cloning efficiency of the colony-forming unit-macrophage (CFU-M) and burst-forming unit-erythroid (BFU-E) compared to cells cultured in medium alone. After culture in IL-4, a limited increase in CFU-granulocyte (CFU-G) and BFU-E is seen, whereas CFU-G, CFU-M, and BFU-E are increased after culture in IL-4 plus IFN-gamma. We further investigated the functional properties of the CD34+CD38++ cells generated in the presence of IFN-gamma. This cell population is highly enriched for BFU-E but partially depleted of CFU-M. Most of the CFU-M were found in the CD34+CD38+/-(CD34+CD38- and CD34+CD38+ cells) population.

摘要

我们研究了白细胞介素-4(IL-4)和干扰素-γ(IFN-γ)对纯化的CD34+骨髓祖细胞上CD38和人类白细胞抗原(HLA)-DR表达的影响。CD34+CD38-和CD34+HLA-DR-细胞在很大程度上是不重叠的群体。在IFN-γ中培养4天后,CD38和HLA-DR的表达显著增加,CD38-和HLA-DR-群体几乎完全消失。此外,IFN-γ诱导出一群CD38表达非常高的CD34+细胞(CD34+CD38++细胞),而初始CD34+群体中不存在这些细胞。IL-4对CD38的表达没有影响,但诱导HLA-DR的表达有有限但显著的增加。与仅在培养基中培养的细胞相比,在IFN-γ中培养后,CD34+细胞显示出更高的集落形成单位-巨噬细胞(CFU-M)和爆式红系集落形成单位(BFU-E)克隆效率。在IL-4中培养后,CFU-粒细胞(CFU-G)和BFU-E有有限的增加,而在IL-4加IFN-γ中培养后,CFU-G、CFU-M和BFU-E均增加。我们进一步研究了在IFN-γ存在下产生的CD34+CD38++细胞的功能特性。该细胞群体富含BFU-E,但CFU-M部分减少。大多数CFU-M存在于CD34+CD38+/-(CD34+CD38-和CD34+CD38+细胞)群体中。

相似文献

1
Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.白细胞介素-4和干扰素-γ对CD34+造血祖细胞上CD38和人类白细胞抗原-DR表达的差异调节
Exp Hematol. 1993 Oct;21(11):1480-6.
2
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.白细胞介素-11刺激人造血CD34+和CD34+CD33-DR-细胞的增殖,并与干细胞因子、白细胞介素-3和粒细胞-巨噬细胞集落刺激因子协同作用。
Exp Hematol. 1993 Dec;21(13):1668-72.
3
Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.表达不同水平HLA-DR、CD33、CD38和c-kit抗原的动员外周血来源CD34+细胞亚群之间的功能差异。
Stem Cells. 1997;15(1):73-81. doi: 10.1002/stem.150073.
4
Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.用My10和主要组织相容性复合体II类单克隆抗体通过双色细胞分选高度富集的成人人类骨髓造血祖细胞的特征分析
J Immunol. 1987 Sep 15;139(6):1823-9.
5
Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.人胎肝中定向和原始髓系及淋巴系造血前体细胞的表型和功能特征
Exp Hematol. 1997 May;25(5):387-94.
6
Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.人白细胞介素 (IL)-9 在无血清条件下可特异性刺激正常人骨髓中 CD34+++DR+CD33- 红系祖细胞的增殖。
Exp Hematol. 1992 May;20(4):418-24.
7
Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.来自胎儿组织、脐带血与成人骨髓及动员外周血的候选造血干细胞。
Exp Hematol. 1998 Nov;26(12):1162-71.
8
Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.一种合成五肽对高度富集的人及小鼠骨髓造血祖细胞的抑制性生物活性:与重组人肿瘤坏死因子-α和干扰素-γ的协同作用。
Exp Hematol. 1989 Oct;17(9):935-41.
9
CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.来自胎儿肝脏、脐带血和成人骨髓的CD34++ CD38-以及CD34+ CD38+人类造血祖细胞,根据其个体发生来源的不同,对造血细胞因子的反应也不同。
Exp Hematol. 1998 Oct;26(11):1034-42.
10
Analysis of bone marrow stem cell.骨髓干细胞分析
Blood Cells. 1994;20(1):45-61; discussion 61-3.

引用本文的文献

1
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.抗 CD38 单克隆抗体可损害多发性骨髓瘤患者 CD34+细胞的动员,并影响其集落形成能力。
Blood Transfus. 2024 Jul;22(4):328-337. doi: 10.2450/BloodTransfus.667.
2
Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody.与血清抗 CD38 单克隆抗体水平升高相关的造血干细胞动员失败。
Eur J Haematol. 2023 Aug;111(2):318-321. doi: 10.1111/ejh.14008. Epub 2023 May 20.
3
Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies.
单克隆抗体对多发性骨髓瘤和 NK 细胞的 CD38 调节作用。
Int J Biol Sci. 2022 Feb 21;18(5):1974-1988. doi: 10.7150/ijbs.68148. eCollection 2022.
4
IFN-γ and CD38 in Hyperprogressive Cancer Development.γ干扰素和CD38在癌症超进展中的作用
Cancers (Basel). 2021 Jan 15;13(2):309. doi: 10.3390/cancers13020309.
5
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias.自然杀伤细胞和 CD38:在浆细胞疾病中的(免疫)治疗意义。
Cells. 2020 Mar 21;9(3):768. doi: 10.3390/cells9030768.
6
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth.达雷妥尤单抗在体外可与骨髓瘤患者动员的CD34+细胞结合,且无细胞毒性或祖细胞生长受损。
Exp Hematol Oncol. 2018 Oct 16;7:27. doi: 10.1186/s40164-018-0119-4. eCollection 2018.
7
Molecular characterization of CD34+ human hematopoietic progenitor cells.CD34+人类造血祖细胞的分子特征
Ann Hematol. 1995 Jun;70(6):281-96. doi: 10.1007/BF01696614.
8
Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells.干扰素γ选择性抑制非常原始的CD342+CD38-人类造血祖细胞,而不抑制更成熟的CD34+CD38+人类造血祖细胞。
J Exp Med. 1994 Sep 1;180(3):1177-82. doi: 10.1084/jem.180.3.1177.